Get the Stockscreener App
18.96
1.58%
0.289
Summit Therapeutics Inc Stock (SMMT) Forecast
The Summit Therapeutics Inc (SMMT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.0592, representing a -73.32% decrease from the current price of $18.96. The highest analyst price target is $5.1909, and the lowest is $4.9274.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SMMT Price Target
Average 7.0619
(-62.75% Downside)
Is Summit Therapeutics Inc (SMMT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.14 | Neutral |
| STOCH(9,6) | 55.26 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.2636 | Buy |
| ADX(14) | 13.09 | Neutral |
| William %R | -26.22 | Neutral |
| CCI(14) | 88.24 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
18.24
Buy
|
18.32
Buy
|
| MA20 |
18.28
Buy
|
18.46
Buy
|
| MA50 |
19.47
Sell
|
18.74
Buy
|
| MA100 |
18.40
Buy
|
17.32
Buy
|
| MA200 |
12.27
Buy
|
13.75
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, SMMT could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on SMMT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 51.14 indicates that SMMT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.26 indicates that SMMT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that SMMT is oversold. This suggests that SMMT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.09 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 88.24 indicates that SMMT is still overbought but not to an extreme extent.
Long-term SMMT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Summit Therapeutics Inc financial reports and earnings history, Summit Therapeutics Inc (SMMT) stock could reach $7.683 by 2030, $22.01 by 2040 and $31.65 by 2050. See the projected annual prices until 2050 of the Summit Therapeutics Inc stock below:
- Summit Therapeutics Inc (SMMT) is expected to reach an average price of $16.64 in 2035, with a high prediction of $16.89 and a low estimate of $16.21. This indicates an $-12.25% rise from the last recorded price of $18.96.
- Summit Therapeutics Inc (SMMT) stock is projected to chart a bullish course in 2040, with an average price target of $21.59, representing an $13.89% surge from its current level. The forecast ranges from a conservative $21.57 to a sky-high $22.01.
- Our analysts predict Summit Therapeutics Inc (SMMT) to jump 36.46% by 2045, soaring from $25.85 to an average price of $25.87, potentially reaching $26.15. While $25.85 is the low estimate, the potential upside is significant.
- Summit Therapeutics Inc (SMMT) stock is expected to climb by 2050, reaching an average of $31.48, a $66.06% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.65 and $30.55, respectively, highlighting the market's uncertainty.
Summit Therapeutics Inc Stock (SMMT) Year by Year Forecast
Summit Therapeutics Inc Stock (SMMT) Price Forecast for 2025
Summit Therapeutics Inc Stock (SMMT) is expected to reach an average price of $7.0619 in 2025, with a high prediction of $9.2909 and a low estimate of $4.8329. This indicates an -62.75% fall from the last recorded price of $18.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.0569 | $4.9274 | $5.1909 | -73.33% |
| February, 2025 | $5.0939 | $4.8329 | $5.2464 | -73.13% |
| March, 2025 | $5.0689 | $4.9789 | $5.4294 | -73.26% |
| April, 2025 | $6.0814 | $5.1251 | $6.8384 | -67.92% |
| May, 2025 | $7.8057 | $5.8879 | $9.2909 | -58.83% |
| June, 2025 | $7.2233 | $6.7868 | $7.8439 | -61.90% |
| July, 2025 | $7.5358 | $7.0858 | $8.3188 | -60.25% |
| August, 2025 | $7.1318 | $6.9457 | $7.5523 | -62.38% |
| September, 2025 | $7.7876 | $7.1083 | $8.0048 | -58.92% |
| October, 2025 | $7.5503 | $7.4063 | $7.9742 | -60.18% |
| November, 2025 | $7.7063 | $7.3833 | $7.8363 | -59.35% |
| December, 2025 | $7.6188 | $7.4328 | $8.0658 | -59.81% |
Summit Therapeutics Inc Stock (SMMT) Price Forecast for 2026
The predicted value for Summit Therapeutics Inc (SMMT) in 2026 is set at an average of $12.26. Estimates vary from a peak of $16.91 to a trough of $7.6018, indicating an -35.35% surge from the present price of $18.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.7548 | $7.6018 | $9.8983 | -53.82% |
| February, 2026 | $10.05 | $8.8113 | $10.42 | -46.99% |
| March, 2026 | $9.8467 | $9.0637 | $10.64 | -48.06% |
| April, 2026 | $11.96 | $9.6132 | $16.91 | -36.92% |
| May, 2026 | $10.74 | $9.7022 | $12.36 | -43.38% |
| June, 2026 | $10.39 | $9.8517 | $11.41 | -45.19% |
| July, 2026 | $10.25 | $9.8343 | $11.54 | -45.92% |
| August, 2026 | $11.73 | $10.60 | $13.56 | -38.13% |
| September, 2026 | $12.51 | $11.18 | $13.05 | -34.00% |
| October, 2026 | $12.95 | $11.80 | $13.35 | -31.70% |
| November, 2026 | $13.09 | $12.12 | $13.51 | -30.93% |
| December, 2026 | $10.24 | $9.8997 | $13.19 | -46.01% |
Summit Therapeutics Inc Stock (SMMT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Summit Therapeutics Inc (SMMT) is $8.9294, with a high forecast of $11.13 and a low forecast of $6.7301. This indicates an -52.90% decrease from the last price of $18.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.27 | $9.9896 | $10.82 | -45.82% |
| February, 2027 | $10.69 | $10.25 | $11.13 | -43.62% |
| March, 2027 | $10.40 | $9.841 | $10.81 | -45.14% |
| April, 2027 | $7.8771 | $7.6676 | $8.5776 | -58.45% |
| May, 2027 | $7.6131 | $7.3951 | $7.9775 | -59.84% |
| June, 2027 | $8.3956 | $7.5696 | $9.0556 | -55.72% |
| July, 2027 | $8.1516 | $8.1016 | $9.1551 | -57.00% |
| August, 2027 | $7.7575 | $7.6975 | $8.5181 | -59.08% |
| September, 2027 | $6.96 | $6.7301 | $7.809 | -63.29% |
| October, 2027 | $6.8961 | $6.8196 | $7.3165 | -63.63% |
| November, 2027 | $7.002 | $6.8425 | $7.1375 | -63.07% |
| December, 2027 | $7.1245 | $6.9006 | $7.195 | -62.42% |
Summit Therapeutics Inc Stock (SMMT) Price Forecast for 2028
In 2028, Summit Therapeutics Inc (SMMT) is projected to reach an average price of $9.6392, with a high projection of $12.24 and a low estimate of $7.0379. This indicates an -49.16% fall from the last price of $18.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.4105 | $7.051 | $7.8375 | -60.91% |
| February, 2028 | $7.3865 | $7.217 | $7.61 | -61.04% |
| March, 2028 | $7.369 | $7.213 | $7.546 | -61.13% |
| April, 2028 | $7.2679 | $7.205 | $7.4185 | -61.67% |
| May, 2028 | $10.10 | $7.0379 | $11.83 | -46.74% |
| June, 2028 | $10.88 | $10.02 | $12.24 | -42.59% |
| July, 2028 | $8.8844 | $8.7494 | $11.29 | -53.14% |
| August, 2028 | $8.1319 | $7.8919 | $9.0158 | -57.11% |
| September, 2028 | $8.2379 | $8.1084 | $8.5979 | -56.55% |
| October, 2028 | $8.9439 | $8.0574 | $8.9739 | -52.83% |
| November, 2028 | $8.6664 | $8.3069 | $9.0404 | -54.29% |
| December, 2028 | $9.4324 | $8.6129 | $9.8359 | -50.25% |
Summit Therapeutics Inc Stock (SMMT) Price Forecast for 2029
The 2029 price forecast for Summit Therapeutics Inc Stock (SMMT) is $10.22 on average, with a high prediction of $12.84 and a low estimate of $7.61. This represents an -46.08% decrease from the previous price of $18.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.1048 | $8.8384 | $9.5589 | -51.98% |
| February, 2029 | $8.8508 | $8.7443 | $9.1863 | -53.32% |
| March, 2029 | $9.0068 | $8.6403 | $9.1168 | -52.49% |
| April, 2029 | $8.8828 | $8.8428 | $9.1498 | -53.15% |
| May, 2029 | $9.1903 | $8.8893 | $9.6003 | -51.53% |
| June, 2029 | $9.4813 | $9.0918 | $9.4913 | -49.99% |
| July, 2029 | $10.03 | $9.4343 | $10.29 | -47.11% |
| August, 2029 | $11.42 | $9.9588 | $12.20 | -39.77% |
| September, 2029 | $12.21 | $10.99 | $12.69 | -35.62% |
| October, 2029 | $11.02 | $10.90 | $12.84 | -41.88% |
| November, 2029 | $11.21 | $10.93 | $12.30 | -40.85% |
| December, 2029 | $7.63 | $7.61 | $12.75 | -59.76% |
Summit Therapeutics Inc Stock (SMMT) Price Forecast for 2030
Summit Therapeutics Inc Stock (SMMT) is expected to reach an average price of $8.8909 in 2030, with a high forecast of $10.58 and a low forecast of $7.205. This signifies an -53.10% decrease from the last price of $18.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.261 | $7.261 | $7.683 | -61.70% |
| February, 2030 | $7.497 | $7.205 | $7.641 | -60.46% |
| March, 2030 | $7.6489 | $7.4562 | $7.6987 | -59.66% |
| April, 2030 | $7.7409 | $7.5649 | $7.7949 | -59.17% |
| May, 2030 | $8.3659 | $7.7439 | $8.3859 | -55.87% |
| June, 2030 | $8.4179 | $8.1289 | $8.5579 | -55.60% |
| July, 2030 | $8.3928 | $8.3498 | $8.5409 | -55.73% |
| August, 2030 | $8.4748 | $8.3188 | $8.6818 | -55.30% |
| September, 2030 | $8.5868 | $8.4778 | $8.7163 | -54.71% |
| October, 2030 | $8.7718 | $8.4558 | $9.0688 | -53.73% |
| November, 2030 | $9.7188 | $8.6678 | $9.7637 | -48.74% |
| December, 2030 | $9.8757 | $9.4497 | $10.58 | -47.91% |
0.22%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):